| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 03/04/2010 | WO2010003765A3 Lepa / guf1 gene sequences as a diagnostic target for the identification of bacterial species |
| 03/04/2010 | WO2009156179A8 Her3 as a determinant for the prognosis of melanoma |
| 03/04/2010 | WO2009154999A3 Methods of identifying inhibitors of gene silencing in mammalian cells |
| 03/04/2010 | WO2009154852A3 Paramagnetic nucleation nanoparticles |
| 03/04/2010 | WO2009151688A3 Direct selection of structurally defined aptamers |
| 03/04/2010 | WO2009145924A3 Methods and materials for identifying patients at heightened risk for developing her2+ related brain tumors |
| 03/04/2010 | WO2009142744A3 Predicting hemostatic risk; dependence on plasma composition |
| 03/04/2010 | WO2009140660A3 System and method for evaluating tissue |
| 03/04/2010 | WO2009140191A3 Detection of disease related gene mutations by single molecule amplification with multiplex ligation assays |
| 03/04/2010 | WO2009139648A3 Methods and compositions for assessment of pulmonary function and disorders |
| 03/04/2010 | WO2009136086A3 Method of screening for antitubercular compounds |
| 03/04/2010 | WO2009132271A3 Risk stratification of genetic disease using scoring of amino acid residue conservation in protein families |
| 03/04/2010 | WO2009132103A3 Microsequencer-whole genome sequencer |
| 03/04/2010 | WO2009129797A4 Stable lysis buffer mixture for extracting nucleic acids |
| 03/04/2010 | WO2009126828A3 Capture agents and related methods and systems for detecting and/or sorting targets |
| 03/04/2010 | WO2009120963A3 Paper-based cellular arrays |
| 03/04/2010 | WO2009120808A3 Restriction endonuclease enhanced polymorphic sequence detection |
| 03/04/2010 | WO2009120557A3 Nanoparticle-mediated signal amplification |
| 03/04/2010 | WO2009117310A3 Methods for treatment and prevention of mrsa/mssa |
| 03/04/2010 | WO2009114531A3 In vivo evolution of hydrogenases using a hydrogen-sensing system |
| 03/04/2010 | WO2009047760A3 Systems and methods for measuring translation activity in viable cells |
| 03/04/2010 | WO2008146938A8 Primers for detecting plasmodium |
| 03/04/2010 | WO2008089226A3 Assessing mammals for vascular diseases |
| 03/04/2010 | WO2007075206A3 Satb1: a determinant of morphogenesis and tumor metastatis |
| 03/04/2010 | US20100058490 Gene Silencing Methods |
| 03/04/2010 | US20100058489 Nucleic Acid Encoding A Brain Derived Tau Kinase Polypeptide and Methods of Use Thereof |
| 03/04/2010 | US20100057370 Nucleotide Sequence Screening |
| 03/04/2010 | US20100056990 Methods and compositions for detection of microbial contaminants in peritoneal dialysis solutions |
| 03/04/2010 | US20100056621 Agonists of a bitter taste receptor and uses thereof |
| 03/04/2010 | US20100056611 MN/CA9 Splice Variants |
| 03/04/2010 | US20100056609 Methods and compositions for inhibition of axonal degeneration by modulation of the dlk/jnk pathway |
| 03/04/2010 | US20100056608 Methods for screening and treatment involving the genes gypc, agpat3, agl, pvrl2, hmgb 3, hsdl2 and/or ldb2 |
| 03/04/2010 | US20100056555 Method of treating ras associated cancer |
| 03/04/2010 | US20100056445 Adiponectin for the treatment and diagnosis of albuminuria |
| 03/04/2010 | US20100056442 Use of gpr101 receptor in methods to identify modulators of hypothalamic proopiomelanocortin (pomc)-derived biologically active peptide secretion useful in the treatment of pomc-derived biologically |
| 03/04/2010 | US20100056435 Depsipeptides and Their Therapeutic Use |
| 03/04/2010 | US20100056390 Pathologically relevant tumor microenvironments for high-throughput drug screening |
| 03/04/2010 | US20100056384 Sequence Variations in PNPLA3 Associated with Hepatic Steatosis |
| 03/04/2010 | US20100056377 Agent for inhibiting cytokinin signaling |
| 03/04/2010 | US20100055800 Compositions for Chemiluminescent Detection of Hydrogen Peroxide |
| 03/04/2010 | US20100055762 Method for Preparation of Hepatocyte Using Es Cell |
| 03/04/2010 | US20100055758 Magnetic Device for Isolation of Cells and Biomolecules in a Microfluidic Environment |
| 03/04/2010 | US20100055745 Producing, Cataloging and Classifying Sequence Tags |
| 03/04/2010 | US20100055735 Ex vivo flow cytometry method and device |
| 03/04/2010 | US20100055734 Methods for Diagnosis and Intervention of Hepatic Disorders |
| 03/04/2010 | US20100055733 Manufacture and uses of reactive microcontact printing of biomolecules on soft hydrogels |
| 03/04/2010 | US20100055732 Cardiac Hypertrophy |
| 03/04/2010 | US20100055731 KEX2 Cleavage Regions OF Recombinant Fusion Proteins |
| 03/04/2010 | US20100055730 Methods for the Diagnosis and Treatment of Female Infertility Using Molecular Markers |
| 03/04/2010 | US20100055729 Sensor device |
| 03/04/2010 | US20100055728 Enzyme sensors, methods for preparing and using such sensors, and methods of detecting protease activity |
| 03/04/2010 | US20100055727 Fluorescence resonance energy transfer (FRET); protease activity of botulinum toxin serotype E (BoNT/E); tetanus toxins |
| 03/04/2010 | US20100055726 having improved thermotolerance, such as improved activity at high temperatures and/or improved thermostability; DNA sequences encoding such improved asparaginases, their production in a recombinant host cell |
| 03/04/2010 | US20100055725 System for assays of aminotransferase |
| 03/04/2010 | US20100055722 Methods of Detecting A Neurological Condition Via Analysis of Circulating Phagocytes |
| 03/04/2010 | US20100055721 Surface Enhanced Raman Scattering and Multiplexed Diagnostic Assays |
| 03/04/2010 | US20100055714 IKB kinase, subunits thereof, and methods of using same |
| 03/04/2010 | US20100055710 Novel Carbohydrate Profile Compositions From Human Cells and Methods for Analysis and Modification Thereof |
| 03/04/2010 | US20100055709 Tubulin Mutation Diagnostic |
| 03/04/2010 | US20100055708 Assay for Chlamydia trachomatis by amplification and detection of Chlamydia trachomatis cytotoxin gene |
| 03/04/2010 | US20100055707 Methods of screening for compounds for use as modulators of left-right asymmetry in scoliotic subjects and for monitoring efficacy of an orthopaedic device |
| 03/04/2010 | US20100055706 Screening Methods for Transfusion Related Acute Lung Injury (TRALI) |
| 03/04/2010 | US20100055705 Compositions and methods for diagnosing and treating cancer |
| 03/04/2010 | US20100055704 Expression profile of thyroid cancer |
| 03/04/2010 | US20100055703 Organism-Specific Hybridizable Nucleic Acid Molecule |
| 03/04/2010 | US20100055702 Pathogenecity Islands of Pseudomonas Aeruginosa |
| 03/04/2010 | US20100055701 Fusion proteins for imaging the nucleus and chromosomes of live cells |
| 03/04/2010 | US20100055700 Role of il-12, il-23 and il-17 receptors in inflammatory bowel disease |
| 03/04/2010 | US20100055699 Method of manufacturing a semiconductor sensor device and semiconductor sensor device obtained with such method |
| 03/04/2010 | US20100055698 Reactor for performing biochemical processes |
| 03/04/2010 | US20100055697 Positive selection of serum proteins for proteomic analysis |
| 03/04/2010 | US20100055696 DRG11-Responsive (DRAGON) Gene Family |
| 03/04/2010 | US20100055695 Method For Generating Aptamers with Improved Off-Rates |
| 03/04/2010 | US20100055694 Molecular signature representative of dysfunctions in epidermal homeostasis |
| 03/04/2010 | US20100055693 Luciferase signal enhancing compositions |
| 03/04/2010 | US20100055692 Method for selection of hop strain, bleeding marker for use in selection of hop strain, and primer set |
| 03/04/2010 | US20100055691 Screening method for therapeutic agent for amyotrophic lateral sclerosis |
| 03/04/2010 | US20100055690 Prognostic biomarkers in patients with ovarian cancer |
| 03/04/2010 | US20100055689 Multifactorial methods for detecting lung disorders |
| 03/04/2010 | US20100055688 Slit2 cancer markers |
| 03/04/2010 | US20100055687 Mutations in the BCR-ABL tyrosine kinase associated with resistance to ST1-571 |
| 03/04/2010 | US20100055686 Methods for diagnosis of pediatric common acute lymphoblastic leukemia by determining the level of gene expression |
| 03/04/2010 | US20100055685 Isothermal detection methods and uses thereof |
| 03/04/2010 | US20100055684 Composition for nucleic acid transfection |
| 03/04/2010 | US20100055683 Diagnosis of pulmonary and/or cardiovascular disease |
| 03/04/2010 | US20100055682 Procedure and methods for detecting alzheimers's disease |
| 03/04/2010 | US20100055681 Primer-directed chromosome painting |
| 03/04/2010 | US20100055680 Genomic dna labeling and amplification |
| 03/04/2010 | US20100055679 Method for the Quantitative Analysis of the Number of Copies of a Pre-Determined Sequence in a Cell |
| 03/04/2010 | US20100055678 Method of profiling a cell population |
| 03/04/2010 | US20100055677 Method for genetic identification of unknown organisms |
| 03/04/2010 | US20100055676 Method of assaying alpha 1, 4-n-acetylglucosamine transferase (alpha 4gnt) mrna |
| 03/04/2010 | US20100055675 Method for detecting measles virus, membrane assay test device, and membrane assay test kit |
| 03/04/2010 | US20100055674 Utilizing liver cell line qsg-7701 to be infected with hepatitis b virus |
| 03/04/2010 | US20100055673 Transparent microfluidic device |
| 03/04/2010 | US20100055672 100% sequence identity detection methods for variable genomes |
| 03/04/2010 | US20100055671 Method for Determining Transduction Efficiency and Virus Dosage of Baculovirus |
| 03/04/2010 | US20100055670 Growth of wild-type hepatitis a virus in cell culture |
| 03/04/2010 | US20100055669 Generation of Recombinant Genes in Bacteriophages |
| 03/04/2010 | US20100055668 Fluid-Transfer Collection Assembly Including Breakable Vial and Method of Using Same |